A $13 million seed investment was secured by AISAP, a Tel Aviv, Israel-based startup that offers an AI-powered point of care assisted diagnostic (POCAD)TM solution to the medical ultrasonography sector.
Investors
- Harel Insurance Investments & Financial Services Ltd.
- L.P.
- Shoni Top Ventures
Use of funds
The money will be used by the business to increase operations and development initiatives.
AISAP, which was founded by Adiel Am-Shalom, Ehud Raanani, Robert Klempfner, and Ehud Schwammenthal, is headed by CEO Roni Attali.
The company offers a POCADTM solution that incorporates AI-powered diagnoses, such as a “urgency score” that allows medical providers to prioritize cases based on the severity of the condition, a score that evaluates the quality of the scan for operators, ensuring accuracy even in situations where they are less experienced with traditional ultrasound devices, and Deep Learning AI capabilities that allow for accurate readings even from handheld machines with lower-quality images. In the cardiovascular systems, the solution may even detect individual valves.
More than 300,000 studies with over 24 million video clips were used to train AISAP’s algorithms, and a number of medical professionals from The Mayo Clinic, Inova Health Foundation, Jefferson Health, Poriya Institute, and other institutions have verified the technology.
